Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | New Horizon for Treatment of Inherited Retinal DystrophyBy: SMi Conferences Daniel will be joined by a senior panel of big pharma and ophthalmic organisations to discuss the latest developments and innovations in ocular gene editing including: Alan Stitt, Dean of Innovation and Impact, Queen's University Belfast Mitchell de long, Vice President, Chemistry, Aerie Pharmaceuticals Naj Sharif, Executive Director and Head, Global Alliances & External Research, Santen Majid Anderesi, Associate Group Clinical Director, Ophthalmology, Roche Caroline Barelle, CEO, Elasmoge Victor Chong, Global Head of Ophthalmology, Boehringer Ingelheim Aniz Girach, Chief Medical Officer, Nightstar Therapeutics Peter Morgan-Warren, Medical Assessor, Licensing Division, MHRA David Silverman, Clinical Director, Ophthalmology, Roche Programme highlights include recent advances in the treatment of glaucoma; recent applications of artificial intelligence in drug discovery and biomarkers and surrogate end-points from a regulatory perspective. https://www.smi- Sponsors: Aero Pump | Experimentica | Nemera ---end--- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|